BHIVA guidelines on the management of HIV in pregnancy and the postpartum period 2025

BHIVA guidelines on the management of HIV in pregnancy and the postpartum period 2025 - British HIV Association (BHIVA)

The BHIVA guidelines on the management of HIV in pregnancy and the postpartum period 2025 have been completely revised, including adding new sections and rewriting and updating existing sections. New sections have been added on HIV screening in pregnancy and preventing HIV acquisition and pre-conception advice, and there is a standalone section on infant feeding which is more detailed than previous guidance.

In this latest version of the guidelines, we have continued to acknowledge the deficit in antiretroviral therapy (ART) pregnancy safety data and paediatric ART availability worldwide. Our aim is to ensure that women/people who are or who may become pregnant can access the best available ART, while highlighting where pregnancy safety and efficacy data are, and are not, available.

These guidelines have been designed to be as accessible, informative and practical as possible. The writing group considered issues reflecting day-to-day practice and queries. For some situations the evidence remains limited, but we recognise that there is a need to provide guidance despite this, to ensure pregnant women/people living with HIV can access an equal standard of personalised care wherever they choose to give birth.


Read full Guideline